Add to ORKGCopyright © 2015 Amit Chopra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Hepatitis C virus infection is the leading cause of chronic liver disease in the United States of America. Pegylated interfero
Pulmonary toxicity is a rare but potentially fatal side effect occurring during interferon (IFN) α t...
Hepatitis C is considered a public health and econom-ic problem worldwide1. An estimated 180 million...
Copyright © 2012 Fabio Forghieri et al. This is an open access article distributed under the Creativ...
Hepatitis C virus infection is the leading cause of chronic liver disease in the United States of Am...
Since 2004, pegylated interferon (P-IFN) in combination with ribavirin has become the optimal choice...
The Author(s) 2009. This article is published with open access at Springerlink.com Abstract Combinat...
Pegylated interferon (Peg-IFN) in combination with ribavirin is the standard of care in the treatmen...
Item does not contain fulltextCombination of peginterferon and ribavirin is the current therapy for ...
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licen...
Background and aim: Hepatitis C virus is a global health problem, and is associated with various hea...
AbstractBackground and aimHepatitis C virus is a global health problem, and is associated with vario...
SummaryWe present a case of Desquamative Interstitial Pneumonitis occurring during treatment with pe...
We present clinical cases, which underline some difficulties in diagnosis and treatment of hepatitis...
Copyright © 2014 Adriano Peris et al. This is an open access article distributed under the Creative ...
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonComme...
Pulmonary toxicity is a rare but potentially fatal side effect occurring during interferon (IFN) α t...
Hepatitis C is considered a public health and econom-ic problem worldwide1. An estimated 180 million...
Copyright © 2012 Fabio Forghieri et al. This is an open access article distributed under the Creativ...
Hepatitis C virus infection is the leading cause of chronic liver disease in the United States of Am...
Since 2004, pegylated interferon (P-IFN) in combination with ribavirin has become the optimal choice...
The Author(s) 2009. This article is published with open access at Springerlink.com Abstract Combinat...
Pegylated interferon (Peg-IFN) in combination with ribavirin is the standard of care in the treatmen...
Item does not contain fulltextCombination of peginterferon and ribavirin is the current therapy for ...
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licen...
Background and aim: Hepatitis C virus is a global health problem, and is associated with various hea...
AbstractBackground and aimHepatitis C virus is a global health problem, and is associated with vario...
SummaryWe present a case of Desquamative Interstitial Pneumonitis occurring during treatment with pe...
We present clinical cases, which underline some difficulties in diagnosis and treatment of hepatitis...
Copyright © 2014 Adriano Peris et al. This is an open access article distributed under the Creative ...
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonComme...
Pulmonary toxicity is a rare but potentially fatal side effect occurring during interferon (IFN) α t...
Hepatitis C is considered a public health and econom-ic problem worldwide1. An estimated 180 million...
Copyright © 2012 Fabio Forghieri et al. This is an open access article distributed under the Creativ...